SAN DIEGO--(BUSINESS WIRE)--Pathway Genomics has received laboratory accreditation from the College of American Pathologists (CAP). With CAP accreditation, Pathway joins an elite group of clinical laboratories around the world that have met exceptionally rigorous standards in order to achieve the highest caliber of quality.
Pathway consists of more than 40 scientific and medical professionals, including medical doctors, scientists, and genetic counselors, as well as an expert scientific advisory board. The company provides genetic tests for drug responses, nutrition and exercise, inherited genetic conditions, and chronic diseases. Pathway’s high-complexity genetic testing laboratory provides its services to patients and corporations through health care practitioners. Pathway also has numerous alliances with large Fortune 500 companies. CAP accreditation serves to further substantiate the accuracy and reliability of the company’s analytical testing procedures in a rapidly growing industry.
The CAP Laboratory Accreditation Program is the premier globally-recognized program and the only one of its kind that utilizes teams of practicing laboratory professionals as inspectors. Designed to exceed government regulatory compliance standards, the program assists laboratories to achieve the highest levels of excellence to positively impact patient care.
“Attaining CAP accreditation is a major milestone for Pathway and demonstrates its laboratory’s ongoing commitment to excellence and the quality of genotyping information for which the company has become known,” said Jim Nickel, M.D., Pathway’s medical laboratory director. “Pathway’s management team commends all of its employees on the outstanding job they did in helping Pathway to become one of the first independent outpatient molecular diagnostic laboratories to achieve this recognition.”
Based on rigorous accreditation standards translated into specific checklist requirements, the goal of the program is to improve patient outcomes by enhancing the quality of pathology and laboratory services through education, as well as the setting and meeting of clear standards.
“Accreditation by CAP is a significant stamp of approval for Pathway,” said Linda Wasserman, M.D., Ph.D., Pathway’s director of clinical genetics. “CAP’s accreditation process is stringent and our approval by them documents our commitment to the highest quality of genetic laboratory medicine.”
Genetic testing is proving to be an effective new technology to change, advance and improve the traditional healthcare system. This specific CAP accreditation further validates the efforts of pioneering and visionary companies, such as Pathway Genomics, that seek to promote the use of personalized medicine in health care.
About the College of American Pathologists
The College of American Pathologists is a medical society that serves more than 17,000 physician members and the laboratory community throughout the world. It is the world’s largest association composed exclusively of Board-certified pathologists and is widely considered the leader in laboratory quality assurance. The College is an advocate for high quality and cost-effective patient care. More information about the College can be found at www.cap.org.
About Pathway Genomics
Located in San Diego, California, Pathway Genomics owns and operates an onsite genetic testing laboratory that is CAP-accredited, CLIA-certified, and licensed by the state of California. Using customized and scientifically validated genetic testing technologies within a controlled and secure environment, Pathway Genomics conducts comprehensive genotyping and targeted sequencing to generate personalized genetic reports. These reports address a variety of genetic issues, including an individual’s carrier status for recessive genetic conditions, metabolism and exercise response, drug or medication response, and propensity to develop certain diseases, such as heart disease, type 2 diabetes, and cancer. Pathway’s genotyping services are available to patients through their physicians and select health management programs.
For more information about Pathway Genomics, visit www.pathway.com.